Leonteq Securities AG cut its stake in Corteva, Inc. (NYSE:CTVA – Free Report) by 67.4% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 11,443 shares of the company’s stock after selling 23,619 shares during the quarter. Leonteq Securities AG’s holdings in Corteva were worth $958,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds also recently modified their holdings of the company. JPL Wealth Management LLC bought a new stake in Corteva during the third quarter worth $25,000. Garton & Associates Financial Advisors LLC bought a new position in Corteva during the 4th quarter valued at $27,000. Bank of Jackson Hole Trust bought a new position in Corteva during the 4th quarter valued at $28,000. Cornerstone Financial Management LLC purchased a new position in Corteva during the 4th quarter worth $29,000. Finally, Basepoint Wealth LLC bought a new stake in shares of Corteva in the 4th quarter worth $30,000. Hedge funds and other institutional investors own 81.54% of the company’s stock.
Analyst Upgrades and Downgrades
Several analysts have recently commented on the stock. The Goldman Sachs Group increased their target price on shares of Corteva from $88.00 to $96.00 and gave the company a “buy” rating in a report on Tuesday, April 14th. Oppenheimer increased their price objective on shares of Corteva from $86.00 to $89.00 and gave the company an “outperform” rating in a research note on Wednesday, April 22nd. Barclays boosted their target price on Corteva from $84.00 to $91.00 and gave the stock an “overweight” rating in a research note on Thursday, June 11th. Berenberg Bank increased their price target on Corteva from $68.00 to $78.00 and gave the company a “hold” rating in a research report on Thursday, March 26th. Finally, Morgan Stanley boosted their price objective on Corteva from $84.00 to $95.00 and gave the stock an “overweight” rating in a research report on Thursday, May 28th. Fourteen equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $88.90.
Corteva Stock Down 0.2%
Corteva stock opened at $85.63 on Friday. The firm has a 50 day moving average price of $79.80 and a 200-day moving average price of $76.86. The company has a quick ratio of 1.03, a current ratio of 1.47 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a twelve month low of $60.53 and a twelve month high of $85.95. The company has a market capitalization of $57.27 billion, a P/E ratio of 50.37, a P/E/G ratio of 2.62 and a beta of 0.56.
Corteva (NYSE:CTVA – Get Free Report) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, topping analysts’ consensus estimates of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The company had revenue of $4.91 billion for the quarter, compared to analysts’ expectations of $4.64 billion. During the same quarter in the previous year, the firm posted $1.13 EPS. Corteva’s revenue was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, equities analysts predict that Corteva, Inc. will post 3.72 EPS for the current year.
Corteva Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Monday, June 15th. Shareholders of record on Monday, June 1st were paid a $0.18 dividend. The ex-dividend date was Monday, June 1st. This represents a $0.72 annualized dividend and a dividend yield of 0.8%. Corteva’s payout ratio is presently 42.35%.
Corteva Company Profile
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Featured Articles
- Five stocks we like better than Corteva
- AST SpaceMobile’s Japan Catalyst Puts Its Rollout Story Back in Focus
- Gold and Silver Recovery—3 Precious Metals Stocks for H2 2026
- Klarna’s Google Court Win Could Give Its BNPL Story a Needed Cash Catalyst
- Why Kroger’s Giant Eagle Deal Could Change Everything
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
